help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 8, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0927
A more recent version of this article appeared on March 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/3/661    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mariot, V.
Right arrow Articles by Linglart, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mariot, V.
Right arrow Articles by Linglart, A.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Calcium and Bone Metabolism

Submitted on April 24, 2007
Accepted on December 20, 2007

A maternal epimutation of GNAS leads to Albright osteodystrophy and PTH resistance

Virginie Mariot, Stéphanie Maupetit-Méhouas, Christiane Sinding, Marie-Laure Kottler, and Agnès Linglart*

INSERM U561, St-Vincent de Paul Hospital, Paris, France; Department of genetic and human reproduction, Centre Hospitalier Universitaire, Caen, France; Paediatric endocrinology and INSERM U561, St-Vincent de Paul Hospital, Paris, France

* To whom correspondence should be addressed. E-mail: linglart{at}ccr.jussieu.fr.

Context: Pseudohypoparathyroidism (PHP) type Ia is a rare maternally transmitted disease due to maternal loss-of-function mutations of GNAS, the gene encoding G{alpha}s, the alpha stimulatory subunit of the G protein. Affected individuals display hormonal resistance (mainly PTH and TSH resistance) and Albright hereditary osteodystrophy. PHP type Ib, usually defined by isolated renal resistance to PTH and sometimes mild TSH resistance, is due to a maternal loss of GNAS exon A/B methylation, leading to decreased G{alpha}s expression in specific tissues.

Objective and Results: We report a girl with obvious Albright osteodystrophy features, PTH resistance, normal G{alpha}s bioactivity in red blood cells, yet no loss-of-function mutation in the GNAS coding sequence (exon 1 through 13). The methylation analysis of the four GNAS Differentially Methylated Regions (DMRs), i.e. NESP, AS, XL and A/B revealed broad methylation changes at all DMRs, including GNAS exon A/B, leading to a paternal epigenotype on both alleles.

Conclusions: This observation suggests that: 1) the decreased expression of G{alpha}s due to GNAS epimutations is not restricted to the renal tubule but may affect nonimprinted tissues like bone; and 2) PHP type Ib is a heterogeneous disorder that should lead to studying GNAS epigenotype in patients with PHP and no mutation in GNAS exon 1–13, regardless of their physical features.


Key words: GNAS • epigenotype • pseudohypoparathyroidism • Albright osteodystrophy







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society